We investigated the correlation between GABRD expression and patient survival with a tissue microarray by immunohistochemistry (IHC) and validated the result with the combined TCGA-colon adenocarcinoma (COAD) and rectal adenocarcinoma (READ) dataset. This evidence concerns the gene GABRD and colon adenocarcinoma.